Skip to content

Post Q3 FY26 Earnings Watchlist: Time to Recalibrate 📊

alt text

Q3 FY26 earnings season is largely behind us.

The next phase is not reaction; it is recalibration.
Capital allocation now depends on execution, guidance, and balance sheet strength.

Author: Priyanshu Jain, Date: 18-02-2026


📊 Mainboard Companies Watchlist

Prices as of market close; 18th February 2026.

Company Market Price (₹)
Jeena Sikho Life 717.70
V2 Retail 2,017.00
Manorama Industries 1,419.60
Vintage Coffee 145.05
Yatharth Hospital 693.35
Sky Gold & Diamonds 378.40
BlackBuck 624.85
Frontier Springs 4,328.65
Arman Financial Services 1,703.00
Capri Global Capital 178.52
Kaynes Technology 4,057.50
Shaily 2,097.20
Neuland Laboratories 13,620.00
Coforge 1,372.80
Quality Power Electrical 879.35
Cupid 422.95
Senores Pharmaceuticals 822.10
Ceinsys Tech Price Pending
Kernex Microsystem 1,137.60
India Grid Trust 164.32

This basket spans:

  • Healthcare
  • Diagnostics
  • Specialty chemicals
  • Electronics manufacturing
  • NBFCs
  • Retail
  • Infra & power
  • IT services

Diversification remains thematic, not accidental.


🏭 MSME Space Watchlist

Higher volatility.
Higher execution dependency.
Potentially higher operating leverage.

Company Market Price (₹)
Aimtron Electronics 848.00
Afcom Holdings 902.05
Chandan Healthcare 275.85
GSM Foils 207.90
Z-Tech (India) 540.25
OBSC Perfection 311.95
Krishna Defence 1,129.60
Shanti Gold International 217.58
V-Marc India 726.20
Grand Continent 123.00
Utssav CZ Gold Jewel 213.45
Bondada Engineering 341.30
Womancart 180.00
Sejal Glass 666.85
Kay Cee Energy & Infra 133.15
Alpex Solar 811.95

MSME names require:

  • Strong balance sheet monitoring
  • Working capital discipline
  • Order book visibility
  • Promoter credibility assessment

Liquidity risk must be priced in.


📈 What Matters Post Earnings

Post Q3, focus shifts to:

  • FY26 guidance vs delivery
  • Margin sustainability
  • Capex intensity vs cash flow
  • Debt trajectory
  • Order book execution
  • Working capital cycle

Price alone does not determine opportunity.
Earnings durability does.


⚖️ Portfolio Allocation Framework

Structured monitoring approach:

  • Core compounders → Strong ROCE + steady earnings
  • Tactical growth → Expansion-led stories
  • High beta bets → MSME / early-stage operators
  • Yield stabilisers → InvITs / infra cash flow plays

Rebalancing must be thesis-driven, not price-driven.


🔍 Final Take

Q3 FY26 provided clarity across sectors.

The next 2–3 quarters will differentiate:

  • Narratives vs numbers
  • Guidance vs execution
  • Expansion vs returns

A disciplined watchlist is not about tracking prices.
It is about tracking business performance.


flowchart TD
    A[Post Q3 Earnings Review]
    A --> B[Revenue & Margin Trends]
    B --> C[Guidance & Order Book]
    C --> D[Capex & Debt Discipline]
    D --> E[Operating Leverage]
    E --> F[Cash Flow Visibility]
    F --> A